Glucozid MR 60 mg is an oral antidiabetic medication containing Gliclazide, a second-generation sulfonylurea, formulated as a modified-release tablet for sustained blood sugar control. It is designed for once-daily administration and provides consistent glycemic control in patients with type 2 diabetes mellitus, especially when lifestyle measures like diet and exercise are insufficient.
Gliclazide works by stimulating insulin secretion from functioning pancreatic beta cells and improving insulin sensitivity, thereby helping to regulate post-meal and fasting glucose levels.